Catalyst
Slingshot members are tracking this event:
PDUFA date set for August 13 2018 for Amicus' (FOLD) migalastat HCL in patients at least 16 years old with Fabry disease who have certain genetic mutations
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
FOLD |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 10, 2018
Occurred Source:
http://ir.amicusrx.com/news-releases/news-release-details/fda-approves-galafoldtm-migalastat-treatment-certain-adult
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Migalastat, Metformin Hcl, Fabry Disease